兴齐眼药
(300573)
| 流通市值：114.38亿 | | | 总市值：148.68亿 |
| 流通股本：1.35亿 | | | 总股本：1.75亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 503,308,315.77 | 390,970,670.92 | 567,852,344.79 | 480,417,942.04 |
| 应收票据及应收账款 | 239,756,857.66 | 272,588,298.64 | 186,372,778.85 | 203,333,839.04 |
| 其中：应收票据 | 17,741,786.94 | 27,729,104.02 | 29,503,885.22 | 25,789,098.73 |
| 应收账款 | 222,015,070.72 | 244,859,194.62 | 156,868,893.63 | 177,544,740.31 |
| 应收款项融资 | 23,254,776.59 | 38,539,232.64 | 33,217,968.81 | 48,769,500.62 |
| 预付款项 | 32,210,809.04 | 36,941,487.9 | 40,592,091.58 | 31,736,915.42 |
| 其他应收款合计 | 3,945,365.22 | 4,563,867.7 | 4,250,215.91 | 3,928,949.31 |
| 存货 | 145,089,102.76 | 149,365,815.14 | 144,615,006.52 | 136,025,273.52 |
| 其他流动资产 | 97,704.31 | 31,101.05 | 17,631.74 | 976,093.87 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 947,662,931.35 | 893,000,473.99 | 976,918,038.2 | 905,188,513.82 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 10,000,000 | 10,000,000 | - | - |
| 投资性房地产 | 12,300,156.8 | 12,533,704.07 | 12,767,251.34 | 13,000,798.61 |
| 固定资产 | 776,980,497.1 | 770,348,159.5 | 752,805,716.44 | 721,348,220.74 |
| 在建工程 | 95,759,332.56 | 82,938,849.61 | 70,835,626.35 | 106,155,765.31 |
| 使用权资产 | 15,491,602.91 | 9,475,587.24 | 8,670,682.54 | 9,847,091.39 |
| 无形资产 | 136,718,742.14 | 139,364,119.11 | 141,691,633.8 | 78,288,437.42 |
| 开发支出 | 64,028,044.86 | 59,172,106.46 | 54,557,135.64 | 109,932,100.1 |
| 长期待摊费用 | 5,738,982.52 | 6,649,388.77 | 7,649,548.29 | 8,829,214.32 |
| 递延所得税资产 | 48,830,586.56 | 50,777,995.36 | 46,243,895.05 | 38,574,731.06 |
| 其他非流动资产 | 72,258,641.35 | 48,445,058.98 | 51,363,630.81 | 32,679,863.45 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,238,106,586.8 | 1,189,704,969.1 | 1,146,585,120.26 | 1,118,656,222.4 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,185,769,518.15 | 2,082,705,443.09 | 2,123,503,158.46 | 2,023,844,736.22 |
| 流动负债: | | | | |
| 短期借款 | 230,177,500 | 250,692,943.66 | 100,087,500 | 70,058,333.31 |
| 应付票据及应付账款 | 18,190,619.6 | 17,324,957.77 | 13,099,227.83 | 17,565,391.85 |
| 应付账款 | 18,190,619.6 | 17,324,957.77 | 13,099,227.83 | 17,565,391.85 |
| 预收款项 | 465,248.6 | 473,026.03 | 159,548.48 | 214,897.61 |
| 合同负债 | 2,362,531.98 | 3,680,917.12 | 5,506,330.14 | 6,548,429.23 |
| 应付职工薪酬 | 75,437,766.05 | 72,975,215.34 | 64,233,736.67 | 77,597,673.93 |
| 应交税费 | 59,815,068.39 | 48,617,171.07 | 24,210,749.27 | 8,468,535.88 |
| 其他应付款合计 | 72,826,583.74 | 86,055,034.63 | 81,990,060.12 | 60,333,333.91 |
| 一年内到期的非流动负债 | 9,420,575.32 | 7,979,685.99 | 8,063,545.91 | 6,865,494.74 |
| 其他流动负债 | 14,555,257.67 | 20,362,119.04 | 15,512,722.37 | 12,466,628.73 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 483,251,151.35 | 508,161,070.65 | 312,863,420.79 | 260,118,719.19 |
| 非流动负债: | | | | |
| 租赁负债 | 7,686,987.88 | 2,175,896.5 | 1,652,338.41 | 2,223,863.17 |
| 递延收益 | 67,068,751.9 | 68,287,987.08 | 72,319,963.1 | 71,581,296.39 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 74,755,739.78 | 70,463,883.58 | 73,972,301.51 | 73,805,159.56 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 558,006,891.13 | 578,624,954.23 | 386,835,722.3 | 333,923,878.75 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 174,424,871 | 174,424,871 | 124,589,194 | 124,589,194 |
| 资本公积 | 862,019,914.65 | 859,780,189.32 | 903,006,712.42 | 891,009,098.6 |
| 盈余公积 | 59,938,445.57 | 59,938,445.57 | 59,938,445.57 | 59,938,445.57 |
| 未分配利润 | 531,379,395.8 | 409,936,982.97 | 649,133,084.17 | 614,384,119.3 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,627,762,627.02 | 1,504,080,488.86 | 1,736,667,436.16 | 1,689,920,857.47 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,627,762,627.02 | 1,504,080,488.86 | 1,736,667,436.16 | 1,689,920,857.47 |
| 负债和股东权益合计 | 2,185,769,518.15 | 2,082,705,443.09 | 2,123,503,158.46 | 2,023,844,736.22 |
| 公告日期 | 2024-10-29 | 2024-08-29 | 2024-04-26 | 2024-04-19 |
| 审计意见(境内) | | | | 标准无保留意见 |